In this connection, we would point out that the “pediatric oligodendrogliomas” (and other low-grade gliomas of the young) reported to date as displaying BRAF and FGFR abnormalities seem not to have been systematically studied for CD34 expression [23, 31, 48]. The gene discussed is CD34; the disease is central nervous system cancer.